PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM), a clinical-stage biopharmaceutical company, announced that the Company will present at several healthcare industry conferences in June 2023. These conferences include:
2023 American Society of Clinical Oncology (ASCO) Annual Meeting
- Yara Abdou, MD, will present trials in progress poster during the meeting:
A phase 1, first-in-human (FIH) study of autologous macrophages engineered to express an anti-HER2 chimeric antigen receptor (CAR) in participants (pts) with HER2-overexpressing solid tumors- Saturday, June 3, 2023, at 8:00 am CT
- Chicago, Illinois
2023 Fierce Biotech Next Gen Virtual Event
- Michael Klichinsky, Pharm.D., Ph.D., Co-Founder & Chief Scientific Officer will give a presentation on Carisma’s revolutionary CAR-M approach.
- Tuesday, June 13, 2023, at 10:00 am ET
- Virtual
- Register to view the webcast here.
CHI’s Immuno-Oncology Summit Europe
- Tom Wilton, Chief Business Officer, will give a presentation titled “CAR-M: Driving Anti-Tumor Immunity with Chimeric Antigen Receptor Macrophages.”
- Wednesday, June 21, 2023, at 5:10 pm BST
- London, United Kingdom
The Cell and Gene Therapy Conference
- Michael Klichinsky, Pharm.D., Ph.D., Co-Founder & Chief Scientific Officer will give a presentation titled “Development of CAR macrophages – a novel approach for solid tumor immunotherapy.”
- Saturday, June 24, 2023, at 2:30 pm ET
- King of Prussia, Pennsylvania
A replay of webcasts, when available, will be posted and archived on Carisma’s Investor Events webpage for a limited time following the event.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and Microsoft Start.